Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Lirilumab

Lirilumab (IPH2102) is an antibody against the lethal immunoglobulin-like receptor antibody KIR2D with antitumor activity that enhances the anti-HPV + cervical cancer activity of natural killer cells through VAV1-dependent NF-κB deinhibition. It can be used to study leukemia, head and neck squamous cell carcinoma (SCCHN) .

Product Specifications

CAS Number

1000676-41-4

Stability

≥ 2 years

Purity

>98% (HPLC)

Molecular Formula

——

Notes

Research use only, not for human use.

Receptor

Virus Protease

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Polyclonal Antibody to Homocysteine (HCy)
TRV-0061971-01 20 µL

Polyclonal Antibody to Homocysteine (HCy)

Sign In for Pricing
View Details
Polyclonal Antibody to Homocysteine (HCy)
TRV-0061971-02 100 µL

Polyclonal Antibody to Homocysteine (HCy)

Sign In for Pricing
View Details
Polyclonal Antibody to Homocysteine (HCy)
TRV-0061971-03 200 µL

Polyclonal Antibody to Homocysteine (HCy)

Sign In for Pricing
View Details
Polyclonal Antibody to Homocysteine (HCy)
TRV-0061971-04 1 mL

Polyclonal Antibody to Homocysteine (HCy)

Sign In for Pricing
View Details
Autoimmune regulator
orb1644188-01 50 µg

Autoimmune regulator

Sign In for Pricing
View Details
Autoimmune regulator
orb1644188-02 100 µg

Autoimmune regulator

Sign In for Pricing
View Details